Related references
Note: Only part of the references are listed.Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Edus H. Warren et al.
BLOOD (2010)
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
Bipulendu Jena et al.
BLOOD (2010)
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
W. M. Liu et al.
BRITISH JOURNAL OF CANCER (2010)
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination
Mohamed Labib Salem et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Adoptive Therapy Using Antigen-Specific T-Cell Clones
Cassian Yee
CANCER JOURNAL (2010)
A High Molecular Weight Melanoma-Associated Antigen-Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas
William R. Burns et al.
CANCER RESEARCH (2010)
Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8+T cell/regulatory T cells in tumour
S. Song et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
Joannes F. M. Jacobs et al.
CLINICAL CANCER RESEARCH (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+T cells exhibit multifunctional effector and helper responses, in vitro
Swagatam Ray et al.
CLINICAL IMMUNOLOGY (2010)
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
Redas Trepiakas et al.
CYTOTHERAPY (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
The evolving role of dendritic cells in cancer therapy
E. J. Ilett et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
The potential of immunomodulatory drugs in the treatment of solid tumors
Angus Dalgleish et al.
FUTURE ONCOLOGY (2010)
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
Anna Merlo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase
Timothy L. Frankel et al.
JOURNAL OF IMMUNOLOGY (2010)
Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma
Shari Pilon-Thomas et al.
JOURNAL OF IMMUNOLOGY (2010)
Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy
Peter A. Prieto et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Administration of Cyclophosphamide Changes the Immune Profile of Tumor-bearing Mice
Pu Liu et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells
Claudia Wrzesinski et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
T-regulatory cell modulation: the future of cancer immunotherapy?
S. Nizar et al.
BRITISH JOURNAL OF CANCER (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients
Daniele Santini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Lotte Engell-Noerregaard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
Christine Galustian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
Thomas Schwaab et al.
CLINICAL CANCER RESEARCH (2009)
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy
U. Laggner et al.
CLINICAL IMMUNOLOGY (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Improving the efficacy of cancer immunotherapy
J. Copier et al.
EUROPEAN JOURNAL OF CANCER (2009)
Immunotherapy for malignant melanoma - Tracing Ariadne's thread through the labyrinth
John M. Grange et al.
EUROPEAN JOURNAL OF CANCER (2009)
Dendritic cell preparation for immunotherapeutic interventions
T. Simon et al.
IMMUNOTHERAPY (2009)
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
Francois M. Lemoine et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones
Amir Khammari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Fludarabine Modulates Immune Response and Extends In Vivo Survival of Adoptively Transferred CD8 T Cells in Patients with Metastatic Melanoma
Herschel Wallen et al.
PLOS ONE (2009)
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Dendritic cell vaccines in melanoma: From promise to proof?
W. J. Lesterhuis et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Tumor-induced modulation of dendritic cell function
Eva Gottfried et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung
J. L. Stanford et al.
EUROPEAN JOURNAL OF CANCER (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma
Nobusada Koike et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
Inge Marie Svane et al.
VACCINE (2008)
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors
Paula Chiarella et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Detection and long-term in vivo monitoring of individual tumor-specific T cell clones in patients with metastatic melanoma
Jaroslav Michalek et al.
JOURNAL OF IMMUNOLOGY (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon
J Banchereau et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
CA Klebanoff et al.
TRENDS IN IMMUNOLOGY (2005)
Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo
YY Lou et al.
CANCER RESEARCH (2004)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Share Paper
